Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of disodium cromoglycate (a mast cell stabilizer) and histamine dihydrochloride. Disodium cromoglycate inhibits degranulation of mast cells, preventing the release of histamine and other inflammatory mediators. It's used to treat mastocytosis, asthma, and allergic conditions. Histamine dihydrochloride is used in the treatment of acute myeloid leukemia and as a topical analgesic. The specific therapeutic purpose of this combination is not well documented in the available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on disodium cromoglycate + histamine dihydrochloride.